درباره این اپیزود
In this episode, I sit down with Dr. Nathan Bryan, one of the world’s leading researchers in nitric oxide physiology and a pioneer who has reshaped how clinicians think about vascular health, metabolism, and the oral microbiome.
Dr. Bryan began his career as a drug discovery chemist, but his work quickly revealed a deeper truth: our ability to generate nitric oxide depends heavily on dietary inputs, oral bacteria, and lifestyle patterns—not just pharmaceuticals. His research uncovered the essential role of the oral microbiome in converting dietary nitrates and nitrites into bioactive nitric oxide, influencing everything from blood pressure to mitochondrial efficiency to immune resilience.
We dig into his groundbreaking contributions, including his founding of Neogenis and the development of the original Neo40 lozenges and nitric oxide indicator test strips, which helped bring NO science into everyday clinical practice. Dr. Bryan also shares how his research has evolved, what most clinicians still misunderstand about nitric oxide biology, and how he’s now advancing the field through his new company, n1o1.com, where he’s translating cutting‑edge nitric oxide science into next‑generation clinical and consumer solutions designed to restore NO production more effectively than ever.
If you’re interested in cardiovascular health, performance, metabolism, or the intersection of the oral microbiome and systemic physiology, this conversation will change the way you think about nitric oxide.
LINKS
Nathan on the Web
Dr. Noseworthy on the Web.
Join the Func Med Nation updates list.
رونوشت 🔗
جستجوی اپیزودهای گذشته
قسمت های دیگر در این پادکست
